Monarc™ Subfascial Hammock
Since 2003, the MonarcTM Subfascial Hammock has been used as a minimally invasive treatment option for female stress urinary incontinence (SUI).
The MonarcTM Subfascial Hammock is the product of choice for many physicians, with more than 700,000 sold worldwide.1 It uses an “outside-in” approach that moves the needles away from obturator nerves and vessels.2
Features + Benefits
- Time-tested AMS Mesh with patented adjustment suture allows for intra-operative sub-urethral adjustment while maintaining mesh integrity3
- Patented centered helix facilitates reliable placement through obturator foramen
Three needle style options to accommodate patient anatomy or physician preference:
Standard MonarcTM Subfascial Hammock features a tight, centered helical needle passer for small, medium, or large patients
MonarcTM Subfacial Hammock+ features a wide, centered helical needle passer designed for larger patients
MonarcTM Subfascial Hammock C offers a needle passer for physicians who prefer the C shape
The MonarcTM Subfascial Hammock has been proven to provide 90% clinical efficacy at 1 year,4 and 89% clinical efficacy at 6.5 years.5
As with any surgical procedure, inherent risks are present. Although rare, some of the most severe risks with sling procedures include infection, erosion, and vessel or urethra perforation. Some of the most common risks include urinary tract infections, urge symptoms, and urinary retention. Do not perform this procedure on pregnant patients.
Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, and potential adverse events. This document is written for professional medical audiences. Contact AMS for lay publications. AMS periodically updates product literature. If you have questions regarding the currency of this information please contact AMS.
Do not undergo this surgery if you are pregnant or know you have sensitivity or allergy to polypropylene mesh products. If you are planning future pregnancies, you should consult with your physician as you may again become incontinent as future pregnancies may make ineffective the effects of the surgical procedure.
Healthcare Professional Resource Center
To help you and your patients optimize your experience with AMS products, we provide many helpful tools.
Here you’ll find a listing of indications, contraindications, warnings, precautions, and potential adverse events, as well as additional product-specific labeling.View Instructions for Use
Give your patients options.
We proudly offer a wide range of quality pelvic health products. Explore more treatment options that may suit your patients’ needs.
1. Data on file.
2. Davila GW, Johnson JD, Serels S. Multicenter experience with the Monarc transobturator sling system to treat stress urinary incontinence. Int Urogynecol J. (2006) Oct.
3. American Medical Systems Test Report: Comparisons of Various Synthetic Meshes Used in Urinary Incontinence Procedures. 2006.
4. Liapis et al, Monarc vs. TVT-O for the treatment of primary stress incontinence: a randomized study; International Urogynecology Journal, August 2007.
5. Heinonen P, Ala-Nissilä S, Räty R, Laurikainen E, Kiiholma P. Objective cure rate and patient satisfaction after the transobturator tape procedure during 6.5-year follow-up. J Minim Invasive Gynecol 2013 Jan-Feb;20(1):73-8. DOI 10.1016/j.jmig.2012.09.007.